Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model

por Mukherjee, Dwaipayan, Zha, Jiuhong, Menon, Rajeev M., Shebley, Mohamad
Publicado 2018

Response Rates as Predictors of Overall Survival: A Meta-Analysis of Acute Myeloid Leukemia Trials

por Agarwal, Suresh K., Mangal, Naveen, Menon, Rajeev M., Freise, Kevin J., Salem, Ahmed Hamed
Publicado 2017

Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse

por Shebley, Mohamad, Menon, Rajeev M., Gibbs, John P., Dave, Nimita, Kim, Su Y., Marroum, Patrick J.
Publicado 2018

Effects of a ritonavir‐containing regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjects

por Zha, Jiuhong, Jiang, Qi, Yao, Betty B., Cohen, Daniel E., Carter, David C., Menon, Rajeev M.
Publicado 2022

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

por Badri, Prajakta S., King, Jennifer R., Polepally, Akshanth R., McGovern, Barbara H., Dutta, Sandeep, Menon, Rajeev M.
Publicado 2015

Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir

por Badri, Prajakta S., Dutta, Sandeep, Wang, Haoyu, Podsadecki, Thomas J., Polepally, Akshanth R., Khatri, Amit, Zha, Jiuhong, Chiu, Yi-Lin, Awni, Walid M., Menon, Rajeev M.
Publicado 2015

Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers...

por Polepally, Akshanth R., King, Jennifer R., Ding, Bifeng, Shuster, Diana L., Dumas, Emily O., Khatri, Amit, Chiu, Yi-Lin, Podsadecki, Thomas J., Menon, Rajeev M.
Publicado 2016